Mira Pharmaceuticals Inc (MIRA)

$1.05

-0.02

(-1.87%)

Market is closed - opens 7 PM, 16 Oct 2024

Performance

  • $1.02
    $1.10
    $1.05
    downward going graph

    2.86%

    Downside

    Day's Volatility :7.27%

    Upside

    4.55%

    downward going graph
  • $0.51
    $6.40
    $1.05
    downward going graph

    51.43%

    Downside

    52 Weeks Volatility :92.03%

    Upside

    83.59%

    downward going graph

Returns

PeriodMira Pharmaceuticals IncIndex (Russel 2000)
3 Months
44.59%
0.0%
6 Months
28.92%
0.0%
1 Year
-62.72%
0.0%
3 Years
-85.58%
-21.9%

Highlights

Market Capitalization
17.7M
Book Value
$0.15
Earnings Per Share (EPS)
-0.86
Wall Street Target Price
11.67
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-177.53%
Return On Equity TTM
-748.59%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-0.86
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.56
EPS Estimate Next Year
-0.49
EPS Estimate Current Quarter
-0.1
EPS Estimate Next Quarter
-0.16

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 1011.43%

Current $1.05
Target $11.67

Technicals Summary

Sell

Neutral

Buy

Mira Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mira Pharmaceuticals Inc
Mira Pharmaceuticals Inc
-16.41%
28.92%
-62.72%
-85.58%
-85.58%
Eli Lilly And Company
Eli Lilly And Company
0.65%
23.81%
50.74%
290.75%
747.32%
Johnson & Johnson
Johnson & Johnson
-3.23%
9.49%
2.58%
0.19%
21.65%
Merck & Co. Inc.
Merck & Co. Inc.
-7.01%
-13.08%
5.33%
40.04%
28.99%
Abbvie Inc
Abbvie Inc
-0.04%
21.02%
32.89%
78.95%
162.62%
Amgen Inc.
Amgen Inc.
-3.17%
22.26%
13.16%
56.19%
58.61%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mira Pharmaceuticals Inc
Mira Pharmaceuticals Inc
NA
NA
NA
-0.56
-7.49
-1.78
NA
0.15
Eli Lilly And Company
Eli Lilly And Company
114.9
114.9
0.88
16.39
0.59
0.14
0.01
15.06
Johnson & Johnson
Johnson & Johnson
24.45
24.45
0.95
9.84
0.22
0.08
0.03
29.72
Merck & Co. Inc.
Merck & Co. Inc.
20.31
20.31
0.08
7.92
0.33
0.11
0.03
17.19
Abbvie Inc
Abbvie Inc
64.95
64.95
0.46
10.86
0.54
0.08
0.03
3.84
Amgen Inc.
Amgen Inc.
55.87
55.87
2.29
19.49
0.49
0.04
0.03
11.03
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mira Pharmaceuticals Inc
Mira Pharmaceuticals Inc
NA
$17.7M
-85.58%
NA
0.0%
Eli Lilly And Company
Eli Lilly And Company
Buy
$839.3B
747.32%
114.9
18.86%
Johnson & Johnson
Johnson & Johnson
Buy
$389.0B
21.65%
24.45
43.91%
Merck & Co. Inc.
Merck & Co. Inc.
Buy
$278.1B
28.99%
20.31
21.99%
Abbvie Inc
Abbvie Inc
Buy
$343.0B
162.62%
64.95
9.71%
Amgen Inc.
Amgen Inc.
Buy
$176.4B
58.61%
55.87
10.12%

Insights on Mira Pharmaceuticals Inc

  • Vs LLY

    In the last 1 year, Eli Lilly And Company has given 52.6% return, outperforming this stock by 115.3%

Company Information

Organization
Mira Pharmaceuticals Inc
Employees
0
CEO
Mr. Erez Aminov
Industry
Miscellaneous

FAQs